Research Paper Volume 13, Issue 9 pp 12865—12895
Integrative analysis identifies key mRNA biomarkers for diagnosis, prognosis, and therapeutic targets of HCV-associated hepatocellular carcinoma
Figure 12. Network pharmacological analysis to identify candidate drugs and effective compounds for therapeutic targets of HCV-HCC. (A) Drug-hub gene network identified from the DGIdb. Green nodes indicate the predictive miRNAs and red nodes indicate the targeted hub genes. (B) Herb-compounds-hub gene network predicted by TCM-MESH and TCM-ID. red nodes indicate hub genes, blue nodes indicate the active compounds and green nodes indicate the putative herbs containing these compounds.